Not applicableStudy completedNCT04713462What this trial is testingReal-world Data of Nivolumab in Pre-treated NSCLCWho this might be right forNon Small Cell Lung Cancer Hellenic Cooperative Oncology Group 346
Testing effectiveness (Phase 2)Ended earlyNCT04375527What this trial is testingBinimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more Jonsson Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06029270What this trial is testingTesting the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal CancerWho this might be right forMetastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8 National Cancer Institute (NCI) 156
Testing effectiveness (Phase 2)Study completedNCT02857569What this trial is testingA Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic MelanomaWho this might be right forStage III/IV Melanoma Gustave Roussy, Cancer Campus, Grand Paris 90
Early research (Phase 1)Study completedNCT03418922What this trial is testingLenvatinib Plus Nivolumab in Participants With Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Eisai Co., Ltd. 30
Early research (Phase 1)Active Not RecruitingNCT03025256What this trial is testingIntravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseWho this might be right forAcral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more M.D. Anderson Cancer Center 75
Not applicableStudy completedNCT02940639What this trial is testingReal-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior TherapyWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 499
Very early researchStudy completedNCT05704933What this trial is testingPilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesWho this might be right forMetastatic MelanomaMetastasis to Brain H. Lee Moffitt Cancer Center and Research Institute 1
Not applicableLooking for participantsNCT07564570What this trial is testingPhysical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in MelanomaWho this might be right forMetastatic Melanoma Universitätsklinikum Hamburg-Eppendorf 40
Early research (Phase 1)Study completedNCT02614456What this trial is testingCombination of Interferon-gamma and Nivolumab for Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Fox Chase Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03647839What this trial is testingModulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal CancerWho this might be right forColorectal Cancer Metastatic Australasian Gastro-Intestinal Trials Group 90
Large-scale testing (Phase 3)Study completedNCT03366272What this trial is testingNivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma PatientsWho this might be right forLymphoma, Non-Hodgkin Universität des Saarlandes 348
Testing effectiveness (Phase 2)Study completedNCT04623775What this trial is testingRelatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung CancerRecurrent Non-small Cell Lung CancerMetastatic Non-small Cell Lung Cancer Bristol-Myers Squibb 468
Large-scale testing (Phase 3)Study completedNCT02713867What this trial is testingA Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 WeeksWho this might be right forLung Cancer Bristol-Myers Squibb 363
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092What this trial is testingAn Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung CancerWho this might be right forResectable Stage IIA to IIIB Non-small Cell Lung Cancer Montefiore Medical Center 17
Testing effectiveness (Phase 2)Ended earlyNCT03655444What this trial is testingAbemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based ChemotherapyWho this might be right forHead and Neck Squamous Cell Carcinoma Washington University School of Medicine 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03635892What this trial is testingNivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced or Metastatic Non-clear Cell Renal Cell CarcinomaUnclassified Renal Cell CarcinomaPapillary Renal Cell Carcinoma+4 more Memorial Sloan Kettering Cancer Center 60
Not applicableStudy completedNCT02910999What this trial is testingReal-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 868
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202What this trial is testingBrentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin LymphomaWho this might be right forAnn Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more City of Hope Medical Center 155
Early research (Phase 1)UnknownNCT04823403What this trial is testingHepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Gustave Roussy, Cancer Campus, Grand Paris 27